Watch industry experts from around the world discuss the findings from the 2021 “Beyond Intervention” research covering challenges in the earliest stages of the vascular patient care, including health equity barriers. Nick West, M.D. Chief Medical Officer and DVP Global Medical Affairs, Abbott’s Vascular Business, is joined by Abbott colleague Jennifer Jones-McMeans, PhD, DVP of Clinical Affairs, David G. Armstrong, D.P.M., M.D., PhD, Progressor of Surgery, Director, USC, and David Rhew, M.D. Chief Medical Officer and VP of Healthcare at Microsoft.
MAT-2301324 v2.0